Connor, Clark & Lunn Investment Management »

Crinetics Pharmaceuticals In shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 21k 51.10
2024-06-30 $902k 20k 44.79

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Toronto Dominion Bk Ont Com New (TD)
Enbridge (ENB)
Agnico (AEM)
Canadian Natl Ry (CNI)
Thomson Reuters Corp. (TRI)
Shopify Cl A (SHOP)
Bk Nova Cad (BNS)
Canadian Pacific Kansas City (CP)
Suncor Energy (SU)
Waste Connections (WCN)
Canadian Natural Resources (CNQ)
Manulife Finl Corp (MFC)
Tc Energy Corp (TRP)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Crinetics Pharmaceuticals In

BlackRock
Driehaus Capital Management
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
Point72 Asset Management
Geode Capital Management
Franklin Resources
Siren
T. Rowe Price Investment Management
OrbiMed Advisors
Novo A/S
First Light Asset Management
Pictet Asset Management Holding SA
Lord, Abbett & Co

View all funds holding Crinetics Pharmaceuticals In